Differential inhibition of thromboxane A2 and prostacyclin synthesis by low dose acetylsalicylic acid in atherosclerotic patients

This publication has 11 references indexed in Scilit:

• Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
  New England Journal of Medicine, 1989
• EFFECTS OF INTERMITTENT TREATMENT WITH ASPIRIN ON THROMBOXANE AND PROSTACYCLIN FORMATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1988
• Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men
  Thrombosis Research, 1988
• Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography-negative-ion chemical ionization mass spectrometry
  Analytical Biochemistry, 1985
• Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet Activation
  New England Journal of Medicine, 1984
• Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
  Journal of Clinical Investigation, 1983
• Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects
  Journal of Clinical Investigation, 1982
• Quantitative analysis of two dinor urinary metabolites of prostaglandin I2
  Analytical Biochemistry, 1981
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
  Nature, 1976
• The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.
  Journal of Clinical Investigation, 1975